
Racial and socioeconomic factors impact aspirin-exacerbated respiratory disease (AERD) diagnosis and treatment. Patients with public insurance are more likely to receive an AERD diagnosis after age 50, while racial disparities affect the completion of aspirin (ASA) desensitization and age at diagnosis. These findings highlight the role of social determinants in influencing healthcare access, adherence, and outcomes for AERD patients, emphasizing the need for equitable healthcare strategies.
Like
Save
Share